The relationship between obesity and functional gastrointestinal disorders: Causation, association, or neither?

Gastroenterology and Hepatology

Volumn 4, Issue 8, 2008, Pages 572-578

  Ho, Wayne ^b   Spiegel, Brennan M R ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Functional gastrointestinal disorders; Irritable bowel syndrome; Obesity

Indexed keywords

CIMETIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; BACTERIAL OVERGROWTH; BARIATRIC SURGERY; BLOATING; BODY MASS; CONSTIPATION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DYSPEPSIA; FUNCTIONAL DISEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LAPAROSCOPIC SURGERY; LOWER ABDOMINAL PAIN; MORBID OBESITY; NAUSEA; OBESITY; PEPTIC ULCER; REVIEW; ROUX Y ANASTOMOSIS; SIDE EFFECT; STOMACH EMPTYING; UPPER ABDOMINAL PAIN; WEIGHT REDUCTION;

EID: 51849088709     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
2. Saito YA, Talley NJ, Melton L, Fett S, Zinmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003;15:687-694.
3. Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22:935-942.
4. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365-1375.
5. Minocha A, Johnson WD, Abell TL, Wiginton WC. Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study. Dig Dis Sci. 2006;51:446-453.
6. van Oijen MG, Josemanders DF, Laheij RJ, van Rossum LG, Tan AC, Jansen JB. Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med. 2006;64:45-49.
7. Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99:1801-1806.
8. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;4:413-419.
9. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99:1807-1814.
10. Svedberg P, Johansson S, Wallander MA, Hamelin B, Pedersen NL. Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study. Aliment Pharmacol Ther. 2002;16:975-983.
11. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agréus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005;54:1377-1383.
12. Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol. 2007;11:1728-1731.
13. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54-59.
14. Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994;35:23-26.
15. Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, et al. Suppression of gastric acid secretion in patients with GERD results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg. 2000;4:50-54.
16. Lewis SJ, Franco S, Young G, O'Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557-561.
17. Crowell MD, Cheskin LJ, Musial F. Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters. Am J Gastroenterol. 1994;89:387-391.
18. Geliebter A, Schachter S, Lohmann-Walter C, Feldman H, Hashim SA. Reduced stomach capacity in obese subjects after dieting. Am J Clin Nutr. 1996;63:170-173.
19. Geliebter A, Hashim SA. Gastric capacity in normal, obese, and bulimic women. Physiol Behav. 2001;74:743-746.
20. Granström L, Backman L. Stomach distension in extremely obese and normal subjects. Acta Chir Scand. 1985;151:367-370.
21. Chiloiro M, Caroli M, Guerra V, Lodadea Piepoli A, Riezzo G. Gastric emptying in normal weight and obese children: an ultrasound study. Int J Obes Relat Metab Disord. 1999;23:1303-1306.
22. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res. 2001;9:655-661.
23. Tosetti C, Corinaldesi R, Stanghellini V, Pasquali R, Corbelli C, et al. Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord. 1996;20:200-205.
24. Wright RA, Krinsky S, Fleeman C, Trujillo J, Teague E. Gastric emptying and obesity. Gastroenterology. 1983;84:747-751.
25. Cardoso-Júnior A, Coelho LG, Savassi-Rocha PR, Vignolo MC, Abrantes MM, et al. Gastric emptying of solids and semi-solids in morbidly obese and non-obese subjects: an assessment using the 13C-octanoic acid and 13C-acetic acid breath tests. Obes Surg. 2007;17:236-241.
26. Verdich C, Madsen JL, Toubro S, Buemann B, Holst JJ, Astrup A. Effect of obesity and major weight reduction on gastric emptying. Int J Obes Relat Metab Disord. 2000;24:899-905.
27. Hellmig S, Von Schöning F, Gadow C, Katsoulis S, Hedderich J, et al. Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol. 2006;21:1832-1838.
28. Hutson WR, Wald A. Obesity and weight reduction do not influence gastric emptying and antral motility. Am J Gastroenterol. 1993;9:1405-1409.
29. Jackson SJ, Leahy FE, McGowan AA, Bluck LJ, Coward WA, Jebb SA. Delayed gastric emptying in the obese: an assessment using the non-invasive 13C acid breath test. Diabetes Obes Metab. 2004;6:264-270.
30. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006;101:2848-2856.
31. Horvath TL, Diano S, Sotonyi P, Heiman M.Tschöp M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology. 2001;142:4163-4169.
32. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-709.
33. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
34. Hansen TK, Dall R, Hosoda H. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol. 2002;56:203-206.
35. Nishizawa T, Suzuki H, Nomoto Y, Masaoka T, Hosoda H, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther Sym Ser. 2006;2:104-110.
36. Shinomiya T, Fukunaga M, Akamizu T, Irako T, Yokode M, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol. 2005;40:648-653.
37. Rey E, Moreno-Elola-Olaso C, Artalejo FR, Locke III GR, Diaz-Rubio M. Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol. 2006;101:229-233.
38. Fraer-Moodie CA, Norton B, Gornall C, Magnago S, Weale AR, Holmes GK. Weight loss has an independent beneficial effect on symptoms of gastrooesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34:337-340.
39. Jacobson BC, Sommers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;355:2340-2348.
40. Kjellin A, Ramel S, Rossner S, Thor K. Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol. 1996;31:1047-1051.
41. Cremonini F, Locke GR III, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006;18:987-994.
42. Poves I, Cabrera M, Maristany C, Coma A, Ballesta-Lopez C. Gastrointestinal quality of life after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16:19-23.
43. Foster A, Laws HL, Gonzalez QH, Clements RH. Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg. 2003;7:750-753.